1. Home
  2. BLMN vs TVTX Comparison

BLMN vs TVTX Comparison

Compare BLMN & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLMN
  • TVTX
  • Stock Information
  • Founded
  • BLMN 1988
  • TVTX 2008
  • Country
  • BLMN United States
  • TVTX United States
  • Employees
  • BLMN N/A
  • TVTX N/A
  • Industry
  • BLMN Restaurants
  • TVTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • BLMN Consumer Discretionary
  • TVTX Health Care
  • Exchange
  • BLMN Nasdaq
  • TVTX Nasdaq
  • Market Cap
  • BLMN 1.4B
  • TVTX 1.5B
  • IPO Year
  • BLMN 2012
  • TVTX N/A
  • Fundamental
  • Price
  • BLMN $12.11
  • TVTX $19.46
  • Analyst Decision
  • BLMN Hold
  • TVTX Buy
  • Analyst Count
  • BLMN 11
  • TVTX 12
  • Target Price
  • BLMN $16.90
  • TVTX $24.58
  • AVG Volume (30 Days)
  • BLMN 1.8M
  • TVTX 1.2M
  • Earning Date
  • BLMN 02-21-2025
  • TVTX 02-13-2025
  • Dividend Yield
  • BLMN 7.95%
  • TVTX N/A
  • EPS Growth
  • BLMN N/A
  • TVTX N/A
  • EPS
  • BLMN N/A
  • TVTX N/A
  • Revenue
  • BLMN $4,547,161,000.00
  • TVTX $203,447,000.00
  • Revenue This Year
  • BLMN N/A
  • TVTX $62.37
  • Revenue Next Year
  • BLMN N/A
  • TVTX $61.74
  • P/E Ratio
  • BLMN N/A
  • TVTX N/A
  • Revenue Growth
  • BLMN N/A
  • TVTX 57.08
  • 52 Week Low
  • BLMN $11.03
  • TVTX $5.12
  • 52 Week High
  • BLMN $30.13
  • TVTX $20.33
  • Technical
  • Relative Strength Index (RSI)
  • BLMN 49.52
  • TVTX 59.31
  • Support Level
  • BLMN $11.15
  • TVTX $16.80
  • Resistance Level
  • BLMN $11.99
  • TVTX $18.76
  • Average True Range (ATR)
  • BLMN 0.55
  • TVTX 0.95
  • MACD
  • BLMN 0.06
  • TVTX 0.09
  • Stochastic Oscillator
  • BLMN 60.00
  • TVTX 89.86

About BLMN Bloomin' Brands Inc.

Bloomin Brands Inc operates as a casual dining restaurant company. The company's brand includes Outback Steakhouse, Carrabba's Italian Grill, Bonefish Grill, and Fleming's Prime Steakhouse and Wine Bar. The company owns and operates its restaurants, and the remainder is franchised. It derives revenue mainly from the United States, but the company has a presence in Brazil and South Korea with company-owned Outbacks and Carrabbas. In addition, it also has exposure to several countries, predominantly in Asia, principally through franchising. The Company aggregates its operating segments into two reportable segments, U.S. and international. The U.S. segment includes all restaurants operating in the U.S. while restaurants operating outside the U.S. are included in the international segment.

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN) - rare kidney disorders that often cause end-stage kidney disease.

Share on Social Networks: